MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$4,347K
EPS
-$0.02
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
1,249
1,266
-883*
1,143
General and administrative
2,975
3,310
-296,483*
151,451
Total operating expenses
4,224
4,576
-297,366
152,594
Gain from operations
-4,224
-4,576
297,366
-152,594
Interest expense
123
-
-
-
Total other expense
-123
-
-
-
Net gain and comprehensive gain
-4,347
-4,576
297,366
-152,594
Basic EPS
-0.02
-0.02
1.43
-0.76
Diluted EPS
-0.02
-0.02
1.43
-0.76
Basic Average Shares
230,209,142
230,209,142
207,882,613
201,686,617
Diluted Average Shares
230,209,142
230,209,142
207,882,613
201,686,617
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net gain and
comprehensive gain
-$4,347K
Gain from operations
-$4,224K
Total other expense
-$123K
Total operating
expenses
$4,224K
Interest expense
$123K
General and
administrative
$2,975K
Research and development
$1,249K
Buy us a coffee
Semnur Pharmaceuticals, Inc. (SMNR)
Semnur Pharmaceuticals, Inc. (SMNR)